心脏交感神经去支配预防遗传介导的致命性室性心律失常
本文综述聚焦长QT综合征(LQTS)和儿茶酚胺敏感性多形性室性心动过速(CPVT),讨论左侧心脏交感神经去支配(LCSD)的临床应用。作者基于约500例LCSD干预经验,强调LCSD的显著疗效应转化为指南导向治疗,以提升精准医学时代的照护质量。
要点
- LQTS和CPVT患者管理不当可致心理伤害或可避免的悲剧。
- LCSD是LQTS和CPVT最常用的心脏交感神经去支配方式。
- 作者基于约500例LCSD经验呼吁将其纳入指南导向治疗。
核心结论
- LCSD对LQTS和CPVT具有显著疗效,应转化为当前和未来指南的导向治疗。
研究设计与样本
- 综述类文章,聚焦LQTS和CPVT,基于作者长期使用LCSD的临床经验,涉及约500例干预。
主要发现
- 作者长期使用LCSD管理LQTS或CPVT患者,并参与了约500例此类干预。
- 管理不当可导致患者因恐惧猝死而生活受限的心理伤害,或未充分利用有效治疗手段而本可避免的悲剧。
临床怎么用
- 临床心脏病学家和电生理学家(成人及儿科)及遗传心脏病学家应重视LCSD在LQTS和CPVT管理中的应用。
- 应将LCSD的显著疗效转化为指南导向治疗,以升级精准医学时代的照护质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Proper management of patients affected by genetic disorders causing life-threatening arrhythmias is important for several reasons, including even societal ones, given the predominantly young age of those affected. Incorrect management often has dire consequences, ranging from unnecessary psychologic damage for the patients whose life becomes too limited by the fear of sudden death to equally avoidable tragedies when the entire armamentarium of effective therapies is not fully utilized. In this review, we focus primarily on long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT) and deal specifically with the clinical impact of the most commonly used cardiac sympathetic denervation (CSD), namely left cardiac sympathetic denervation (LCSD). The two of us have used LCSD in the management of our patients with either LQTS or CPVT for a very long time and have been involved in ∼500 such interventions. It is on the basis of this personal and direct experience that we wish to share our views with clinical cardiologists and electrophysiologists, adult and paediatric, and with genetic cardiologists. We will begin by reviewing the history and rationale underlying sympathetic denervation therapy and will continue with a disease-specific intensification of therapy, and then with a discussion on how the impressive efficacy of LCSD should translate into guideline-directed therapy in both current and future guidelines, in order to upgrade the quality of care in the era of precision medicine.
引用
- Schwartz PJ, Ackerman MJ. Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias. Eur Heart J. 2022. PMID: 35301528. doi:10.1093/eurheartj/ehac134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。